Skip to main content

Table 3 Median values (interquartile spacing) of the two lymphocyte counts, lymphocyte subsets, and dendritic cells after treatment

From: Effect of immune-modulating metronomic capecitabine as an adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma

Group

Lymphocyte count

CD4+

CD8+

CD28 + CD4+

Activated CD4+

CD28 + CD8+

Activated CD8+

CD4/CD8 ratio

CD3+

PDCs

MDCs

Experimental group

1.48 × 109(1.06–1.86 × 109)

22.30(15.90–31.30)

26.22(8.10–44.90)

18.40(10.10–30.70)

2.50(0.40–6.10)

10.20(5.40–17.90)

8.10(0.20–12.40)

1.23(0.44–2.76)

57.40(30.60–75.30)

2.50(1.20–5.90)

5.60(0.97–10.79)

Control group

1.85 × 109(1.30–1.98 × 109)

20.31(14.00-44.30)

17.25(14.30–37.70)

18.50(11.60–42.00)

3.42(0.72–7.76)

7.75(6.00-14.20)

2.95(0.96–12.29)

0.93(0.30–1.49)

52.39(43.00-68.36)

2.33(0.40-5.00)

3.80(0.40–16.30)

Z

0.298

0.51

-4.86

0.90

0.55

-2.19

-3.05

-2.01

-4.81

-1.00

-2.30

P

0.185

0.84

0.03

0.73

0.46

0.03

0.04

0.06

0.18

0.13

0.05